Overcoming Challenges in the Development of Antibody Drug Conjugates
Andreas Dreps, Senior VP and Global Head Drug Development Unit, ICON plc Over the years, extensive research and clinical trials…
Unraveling Stories Connecting Communities
Andreas Dreps, Senior VP and Global Head Drug Development Unit, ICON plc Over the years, extensive research and clinical trials…
Image credit: florence | stock.adobe.com In the Phase I/II CHORD trial (NCT05788536), a novel gene therapy was found to restore…
Image credit: MdBabul | stock.adobe.com Keytruda (pembrolizumab; Merck) plus chemotherapy as adjuvant therapy, with or without radiotherapy, in the treatment of…
ACT: Ken, could you give us an overview of the risk-based quality management (RBQM) study conducted by Tufts? Getz: Yes,…
Image credit: JHVEPhoto | stock.adobe.com The FDA has notified Moderna that it will be unable to finish reviewing its Biologics…
Image Credit: © NicoElNino – stock.adobe.com The Tufts Center for the Study of Drug Development (Tufts CSDD) is conducting an…
Image Credit: © putilov_denis – stock.adobe.com Patient enrollment has been a persistent challenge in clinical trials over the years across…
Image Credit: Adobe Stock Images/_veiksme_ The Pistoia Alliance, a prominent non-profit advocating for increased collaboration in life sciences R&D, announced…
Image credit: Jafree | stock.adobe.com Diarrheal diseases place a significant burden on public health in India, particularly among children and…
Image Credit: © ibreakstock | stock.adobe.com The FDA has granted Breakthrough Device Designation for Teal Health’s Teal Wand, a novel…